RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma

T Sakurai1, K Isogaya1, S Sakai1

  • 1Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Oncogene
|March 1, 2016
PubMed

Insights

RNA-binding motif protein 47 (RBM47) acts as a tumor suppressor by inhibiting nuclear factor erythroid 2-related factor 2 (Nrf2) activity. Loss of RBM47 promotes cancer progression and metastasis, highlighting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • RNA-binding proteins regulate gene expression post-transcriptionally during cancer progression.
  • Transforming growth factor-beta (TGF-β) signaling influences epithelial-to-mesenchymal transition (EMT).

Purpose of the Study:

  • To investigate the role of RNA-binding motif protein 47 (RBM47) in cancer.
  • To elucidate the mechanism by which RBM47 affects cancer progression and its relationship with TGF-β and Nrf2 signaling.

Main Methods:

  • Identification of RBM47 as a TGF-β target gene in NMuMG cells undergoing EMT.
  • Analysis of RBM47 expression in human cancer patient data (lung, breast, gastric).
  • Investigated RBM47's interaction with KEAP1 and Cullin 3 mRNAs and its effect on Nrf2 activity.
  • Assessed RBM47's impact on mitochondrial respiration and cancer cell populations.
  • Evaluated RBM47's role in tumor formation and metastasis in xenograft mouse models.

Main Results:

  • TGF-β repressed RBM47 expression in epithelial and lung cancer cells.
  • RBM47 expression correlated with favorable prognosis in lung, breast, and gastric cancers.
  • RBM47 suppressed cell metabolism genes targeted by Nrf2.
  • RBM47 knockdown led to increased Nrf2 activity, enhanced Nrf2 activator expression, elevated mitochondrial respiration, and increased side population cells.
  • RBM47 knockdown promoted tumor formation and metastasis in vivo.

Conclusions:

  • RBM47 exhibits tumor-suppressive functions by inhibiting Nrf2 activity.
  • RBM47 plays a critical role in regulating cancer cell metabolism and progression.
  • RBM47 represents a potential therapeutic target for inhibiting cancer growth and metastasis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
5.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.4K